- Home
- SLGL vs NXPL Comparison
SLGL vs NXPL Comparison
Compare SLGL & NXPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLGL
- NXPL
- Stock Information
- Founded
- SLGL 1997
- NXPL 1997
- Country
- SLGL Israel
- NXPL United States
- Employees
- SLGL N/A
- NXPL N/A
- Industry
- SLGL Biotechnology: Pharmaceutical Preparations
- NXPL Telecommunications Equipment
- Sector
- SLGL Health Care
- NXPL Telecommunications
- Exchange
- SLGL Nasdaq
- NXPL Nasdaq
- Market Cap
- SLGL 19.3M
- NXPL 17.9M
- IPO Year
- SLGL 2018
- NXPL N/A
- Fundamental
- Price
- SLGL $7.26
- NXPL $0.75
- Analyst Decision
- SLGL Buy
- NXPL
- Analyst Count
- SLGL 1
- NXPL 0
- Target Price
- SLGL $40.00
- NXPL N/A
- AVG Volume (30 Days)
- SLGL 25.3K
- NXPL 27.9K
- Earning Date
- SLGL 08-15-2025
- NXPL 08-13-2025
- Dividend Yield
- SLGL N/A
- NXPL N/A
- EPS Growth
- SLGL N/A
- NXPL N/A
- EPS
- SLGL N/A
- NXPL N/A
- Revenue
- SLGL $12,103,000.00
- NXPL $62,515,000.00
- Revenue This Year
- SLGL N/A
- NXPL N/A
- Revenue Next Year
- SLGL $31.17
- NXPL N/A
- P/E Ratio
- SLGL N/A
- NXPL N/A
- Revenue Growth
- SLGL 603.66
- NXPL 19.36
- 52 Week Low
- SLGL $3.34
- NXPL $0.43
- 52 Week High
- SLGL $16.50
- NXPL $2.30
- Technical
- Relative Strength Index (RSI)
- SLGL 52.97
- NXPL 59.43
- Support Level
- SLGL $7.02
- NXPL $0.65
- Resistance Level
- SLGL $7.58
- NXPL $0.77
- Average True Range (ATR)
- SLGL 0.37
- NXPL 0.06
- MACD
- SLGL 0.02
- NXPL 0.00
- Stochastic Oscillator
- SLGL 41.28
- NXPL 73.33
About SLGL Sol-Gel Technologies Ltd.
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.
About NXPL NextPlat Corp
NextPlat Corp is an e-commerce and healthcare company. Its e-commerce venues form an effective network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operates in two segments: e-Commerce Operations involves acquiring and leasing an e-commerce platform; and Healthcare Operations provides TPA, data management, COVID-19 related diagnostics and vaccinations, prescription pharmaceuticals, and Others.